- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Saroja Pharma Industries India has announced a board meeting to approve the financial results for the quarter and half-year, with clean auditor feedback. The company used Rs. 66.7 Cr to build a new manufacturing unit, repaid Rs. 1.75 Cr of unsecured loans, and spent Rs. 0.31 Cr on public issue costs, leaving around Rs. 3.8 Cr unutilized. No dividends or new appointments were announced, signaling a clear focus on expanding operations and strengthening its financial position.
All announcements from Saroja Pharma Industries India Limited